These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 305464)

  • 41. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
    Mayumi H; Good RA
    J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure and viral interactions of H-2 antigens.
    Cunningham BA; Reske K; Milner RJ; Schrader JW; Ziffer JA
    Birth Defects Orig Artic Ser; 1978; 14(2):203-16. PubMed ID: 76484
    [No Abstract]   [Full Text] [Related]  

  • 43. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigen receptors on major histocompatibility complex-restricted T lymphocytes. I. Preparation and characterization of syngeneic antisera against trinitrophenyl-activated T cell blasts and demonstration of their specificity for idiotypes on cytotoxic T lymphocytes.
    Krammer PH; Rehberger R; Eichmann K
    J Exp Med; 1980 May; 151(5):1166-87. PubMed ID: 6154768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
    Billings P; Burakoff SJ; Dorf ME; Benacerraf B
    J Exp Med; 1978 Aug; 148(2):341-50. PubMed ID: 100567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes.
    Sherman LA
    J Exp Med; 1982 Feb; 155(2):380-9. PubMed ID: 6173455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11.
    Giorgi JV; Burton RC; Scott D; Warner NL
    Int J Cancer; 1982 Jan; 29(1):119-26. PubMed ID: 6977499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors.
    Gomard E; Levy JP; Plata F; Henin Y; Duprez V; Bismuth A; Reme T
    Eur J Immunol; 1978 Apr; 8(4):228-36. PubMed ID: 78851
    [No Abstract]   [Full Text] [Related]  

  • 51. Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes.
    Duprez V; Mescher MF; Burakoff SJ
    J Immunol; 1983 Jan; 130(1):493-5. PubMed ID: 6600194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biologic effects of allogeneic effect factor on T lymphocytes. I. The mitogenic activity and the autonomous induction of cytotoxic T lymphocytes by AEF.
    Altman A; Cardenas JM; Bechtold TE; Katz DH
    J Immunol; 1980 Jan; 124(1):105-13. PubMed ID: 6444223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex alloantigens.
    Burakoff SJ; Ratnofsky SE; Benacerraf B
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4572-6. PubMed ID: 73180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The induction of cytolytic T lymphocytes with specificity for p-azophenylarsonate coupled syngeneic cells.
    Sherman LA; Burakoff SJ; Benacerraf B
    J Immunol; 1978 Oct; 121(4):1432-6. PubMed ID: 81234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines.
    Das B; Mondragon MO; Sadeghian M; Hatcher VB; Norin AJ
    J Exp Med; 1994 Jul; 180(1):273-81. PubMed ID: 8006588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
    Seung S; Urban JL; Schreiber H
    J Exp Med; 1993 Sep; 178(3):933-40. PubMed ID: 8394406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Augmentation of in vivo cytotoxic T lymphocyte activity and reduction of tumor growth by large multivalent immunogen.
    Rogers J; Mescher MF
    J Immunol; 1992 Jul; 149(1):269-76. PubMed ID: 1607658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.
    Bonavida B
    J Exp Med; 1977 Feb; 145(2):293-301. PubMed ID: 299880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P; Leidig S; Heckl-Oestreicher B
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell surface glycoproteins of cytotoxic T lymphocytes induced in vivo and in vitro.
    Kaufmann Y; Berke G
    J Immunol; 1981 Apr; 126(4):1443-6. PubMed ID: 6451646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.